MVZ Johanniter Onkologie Bonn Rhein Sieg Johanniter- MVZ Bonn GmbH
- Address
- Europaring 42, 53123 Bonn, Germany
Non‑small Cell Lung Cancer Trials
The MVZ Johanniter Onkologie Bonn‑Rhein‑Sieg is dedicated to advancing treatment for non‑small cell lung cancer, focusing on new drug combinations that may improve safety and effectiveness for patients.
- Safety and tolerability of investigational agents
- Efficacy comparison with existing immunotherapy regimens
- Pharmacokinetic profiling of novel compounds
- Assessment of patient quality‑of‑life outcomes
Collaboration with a dedicated investigator supports the generation of data that could influence future standards of care for this prevalent lung cancer subtype.
Small Cell Lung Cancer Research
The Bonn site conducts focused studies on small cell lung cancer, seeking innovative therapies to extend survival for individuals with relapsed disease.
- Anti‑tumor activity of new investigational drugs
- Overall survival benefits versus physician‑selected therapies
- Combination approaches with standard chemotherapy
- Biomarker‑driven patient selection strategies
These trials aim to provide evidence for more effective treatment options, reflecting the center’s commitment to progress in a challenging therapeutic area.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1BioNTech SE1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in MVZ Johanniter Onkologie Bonn Rhein Sieg Johanniter- MVZ Bonn GmbH
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of BNT327 Combined with Chemotherapy and Investigational Agents in First-Line Treatment of Non-Small Cell Lung Cancer | BioNTech SE | Phase IV | Recruiting | Jun 2025 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| BNT327 | 1 | Unknown | 2025-06-13 | 2025-06-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.